Kriti Mittal to Protein Kinase Inhibitors
This is a "connection" page, showing publications Kriti Mittal has written about Protein Kinase Inhibitors.
Connection Strength
0.795
-
Mittal K, Derosa L, Albiges L, Wood L, Elson P, Gilligan T, Garcia J, Dreicer R, Escudier B, Rini B. Drug Holiday in Metastatic Renal-Cell Carcinoma Patients Treated With Vascular Endothelial Growth Factor Receptor Inhibitors. Clin Genitourin Cancer. 2018 06; 16(3):e663-e667.
Score: 0.490
-
Ky B, Liu T, Margulies KB, Mitchell JD, Haas NB, Gareen IF, Thangarajah M, Sicks JD, Domenico C, Narayan VK, Smith AM, Wilcox NS, Mittal K, Rhee JW, Armenian SH, Saphner T, Paul AK, Gartrell BA, Zaha VG, Anari F, Wong RL, Townsend RR, Wagner LI. Cluster Randomized Controlled Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191. Hypertension. 2026 Jul; 83(7):e26016.
Score: 0.219
-
Mittal K, Rini B. Kidney cancer in 2012: new frontiers in kidney cancer research. Nat Rev Urol. 2013 Feb; 10(2):70-2.
Score: 0.087